Mechanistic Evaluation of Glucose-lowering Strategies in Patients With Heart Failure

Clinical trial NCT02917031 · COMPLETED

Trial details

NCT number: NCT02917031
Sponsor: AstraZeneca
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Type 2 Diabetes Mellitus Heart Failure

Start date: 2017-01-10
Primary completion: 2019-08-23
Enrollment: 348

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.